跳至主要内容
临床试验/IRCT20220818055740N2
IRCT20220818055740N2已完成3 期

Determination of the therapeutic efficacy of ginger in the treatment of migraine headaches

Shahre-kord University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18 to 65 years; history of migraine headache before performing the study based on IHS criteria; headache from moderate to severe less than six days by visual analogue score(Vas); absence of diseases such as liver, heart, active stomach ulcer, diabetes and renal failure.

排除标准

  • Abnormal vital signs during the study;, new abnormal findings during CT scan; dissatisfaction patients to continue the study;, and observation of drug sensitivity.

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验

Determination of the therapeutic efficacy of ginger... | 临床试验